Assure Tech Hangzhou Co Ltd (688075) - Total Liabilities
Based on the latest financial reports, Assure Tech Hangzhou Co Ltd (688075) has total liabilities worth CN¥611.60 Million CNY (≈ $89.50 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Assure Tech Hangzhou Co Ltd to track the company's year-over-year net asset growth rate.
Assure Tech Hangzhou Co Ltd - Total Liabilities Trend (2017–2025)
This chart illustrates how Assure Tech Hangzhou Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688075 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Assure Tech Hangzhou Co Ltd Competitors by Total Liabilities
The table below lists competitors of Assure Tech Hangzhou Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs8.40 Billion |
|
Beijing Bewinner Communications Co Ltd
SHE:002148
|
China | CN¥148.73 Million |
|
Cimentas Izmir Cimento Fabrikasi TAS
IS:CMENT
|
Turkey | TL5.93 Billion |
|
Pagerduty Inc
NYSE:PD
|
USA | $719.85 Million |
|
Yaari Digital Integrated Services Limited
NSE:YAARI
|
India | Rs11.02 Billion |
|
Brandywine Realty Trust
NYSE:BDN
|
USA | $2.85 Billion |
|
SECHE ENVIRO.UNSP.ADR 1/5
F:SCB0
|
Germany | €1.67 Billion |
|
Eastern Polymer Group Public Company Limited
BK:EPG
|
Thailand | ฿7.38 Billion |
Liability Composition Analysis (2017–2025)
This chart breaks down Assure Tech Hangzhou Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688075 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Assure Tech Hangzhou Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Assure Tech Hangzhou Co Ltd (2017–2025)
The table below shows the annual total liabilities of Assure Tech Hangzhou Co Ltd from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥515.98 Million ≈ $75.50 Million |
-9.40% |
| 2024-12-31 | CN¥569.52 Million ≈ $83.34 Million |
-16.72% |
| 2023-12-31 | CN¥683.83 Million ≈ $100.07 Million |
-55.10% |
| 2022-12-31 | CN¥1.52 Billion ≈ $222.85 Million |
+125.97% |
| 2021-12-31 | CN¥673.95 Million ≈ $98.62 Million |
+133.02% |
| 2020-12-31 | CN¥289.22 Million ≈ $42.32 Million |
+418.82% |
| 2019-12-31 | CN¥55.75 Million ≈ $8.16 Million |
-34.05% |
| 2018-12-31 | CN¥84.53 Million ≈ $12.37 Million |
-11.94% |
| 2017-12-31 | CN¥95.99 Million ≈ $14.05 Million |
-- |
About Assure Tech Hangzhou Co Ltd
Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veteri… Read more